This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1945 and headquartered in Victor, NY, Constellation Brands Inc. produces and markets beer, wine and spirits. It is the third-largest beer company and a leading, high-end wine company in the United States. It has a strong portfolio of high-quality brands, including Corona, Modelo Especial, Robert Mondavi, Kim Crawford, Meiomi and SVEDKA Vodka. The company conducts its operations in the United States, Mexico, Italy and New Zealand.
Constellation Brands Tops Q3 Earnings, View Cut Hurts Stock
by Zacks Equity Research
Constellation Brands' (STZ) top and bottom lines beat estimates in third-quarter fiscal 2019. However, the company lowers view for fiscal 2019.
Will Bed Bath & Beyond Disappoint? & News from AAPL, STZ, LEN
by Ryan McQueeney
Ryan McQueeney discusses fresh commentary from Fed officials and news involving Apple, Constellation Brands, and Lennar. Later, he previews the upcoming earnings report of struggling retailer Bed Bath & Beyond.
Pot Stocks in 2019: A Year of Transition
by Tracey Ryniec
In 2018, investors pinned their pot stock hopes on Canadian legalization but in 2019 the game has changed. Who will emerge as the winners?
Constellation Brands (STZ) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Constellation Brands (STZ) delivered earnings and revenue surprises of 16.18% and 3.25%, respectively, for the quarter ended November 2018. Do the numbers hold clues to what lies ahead for the stock?
This Week's Must Watch Earnings Reports
by Tracey Ryniec
Fourth quarter earnings season is about to heat up and these companies will give you some early clues.
The Top Cannabis Investing Storylines to Watch in 2019
by Ryan McQueeney
Ryan McQueeney chats with Zacks Stock Strategist Dave Borun about the top cannabis investing storylines to watch in 2019, including new legal issues, the most exciting areas for growth, and a new model portfolio that will feature some of the industry's top stocks.
Steelcase, Apollo Global Management, Lennar, Constellation Brands and Bed Bath & Beyond highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Steelcase, Apollo Global Management, Lennar, Constellation Brands and Bed Bath & Beyond highlighted as Zacks Bull and Bear of the Day
Upcoming Earnings to Watch: LEN, STZ, BBBY
by Ryan McQueeney
Stocks whipsawed this week, just in time for the first wave of earnings reports to help motivate the direction of the market. Let's take a closer look at a few of the earnings announcements due during the week of January 7.
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Altria, Constellation, Anheuser-Busch and The Stars
by Zacks Equity Research
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Altria, Constellation, Anheuser-Busch and The Stars
Here's Why Owens-Illinois (OI) is Worth Buying Right Now
by Zacks Equity Research
Owens-Illinois (OI) rides on increased preference of customers for glass packaging and promises better rewards for investors.
Two Dividend-Paying 'Sin Stocks' To Watch Right Now
by Ryan McQueeney
Ryan McQueeney highlights two "sin stocks"---Vector Group (VGR) and Constellation Brands (STZ)---that present mixed-yet-unique investment possibilities for dividend-focused investors.
Does AB InBev (BUD) Stock Have Potential to Rebound in 2019?
by Zacks Equity Research
AB InBev (BUD) suffers on account of softness in the beer industry, particularly in the United States, which is hurting its sales. However, its recent venture in cannabis space is encouraging.
4 Sinfully Good Stocks to Watch in 2019
by Tirthankar Chakraborty
Given the stock market turbulence and specter of slower economic growth this year, investing in sin stocks seems prudent. The products or services in this space are relatively inelastic, and business is recession-proof.
Constellation Brands (STZ) to Keep Earnings Beat Trend in Q3
by Zacks Equity Research
Constellation Brands' (STZ) strengthening beer business has been aiding its performance over the last several quarters. Additionally, brand building and product innovation efforts are key revenue drivers.
Owens-Illinois Poised on Favorable Glass Demand, Debt Rises
by Zacks Equity Research
The growing preference for glass packaging bodes well for the Owens-Illinois (OI).
AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal
by Zacks Equity Research
AB InBev (BUD) announces partnership with the leading marijuana producer, Tilray.
Can Constellation Brands (STZ) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Constellation Brands (STZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Factors Likely to Influence NIKE's (NKE) Earnings in Q2
by Zacks Equity Research
NIKE's (NKE) earnings and sales are likely to benefit from robust innovation efforts as well as strength in international business and the global NIKE Direct business.
4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
by Sanghamitra Saha
These are the factors that could send marijuana stocks and ETF high in 2019.
Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation
by Zacks Equity Research
Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation
Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest
by Ryan McQueeney
Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.
Costco (COST) Q1 Earnings: Growth Momentum Likely to Sustain
by Zacks Equity Research
Costco (COST) continues to be one of the dominant retail wholesalers based on the breadth and quality of merchandise offered.
The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
Cronos Group (CRON) Soars on C$2.4B Investment from Altria
by Zacks Equity Research
Cronos Group (CRON) receives a significant boost with C$2.4-billion equity investment from tobacco giant Altria Group.
Here's Why You Should Hold Constellation Brands Stock Now
by Zacks Equity Research
Constellation Brands (STZ) is a favored stock, owing to its robust surprise trend, strength in the beer business and solid business growth plans, including investment in Canopy Growth.